Matinas BioPharma Holdings, Inc. (MTNB)
After hours:
| Previous Close | 0.5799 |
| Open | 0.5625 |
| Bid | 0.5900 x 800 |
| Ask | 0.6000 x 1000 |
| Day's Range | 0.5426 - 0.6600 |
| 52 Week Range | 0.5000 - 21.5000 |
| Volume | |
| Avg. Volume | 211,379 |
| Market Cap | 3.133M |
| Beta (5Y Monthly) | 1.73 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.7400 |
| Earnings Date | Nov 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireMatinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203, its oral formulation of amphotericin B, have been terminated following notification from the prospective partner. As a result, Matinas has implemented an 80% workforce reduction effective immediately, eliminating 15 positions including three members of senior management, and
TipRanksUpcoming Stock Splits This Week (September 2 to September 6) – Stay Invested
These are the upcoming stock splits for the week of September 2 to September 6, based on TipRanks’ Stock Splits Calendar. A stock split is a corporate action in which the company issues additional common shares to increase the number of outstanding shares. Accordingly, the stock price of the company’s shares decreases, which maintains the market capitalization before and after the split. In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate).
